Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

8.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

738
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
738
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

617
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
617

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain protein burden is related to intravoxel incoherent motion: PET-MR imaging study.

Frontiers in neuroscience·2026
Same author

177Lutetium-PSMA-I&T therapy for metastatic castration-resistant prostate cancer (mCRPC): the first multicenter real-world study of 177Lu-PSMA-I&T in Brazil.

EJNMMI reports·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

[18F]PI-2620 Tau PET signal across the aging and Alzheimer's disease clinical spectrum.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408.

Blood neoplasia·2025
Same author

<sup>18</sup>F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease.

Brain communications·2025

Related Experiment Video

Updated: Mar 21, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K

FDG-PET/CT Initial and Subsequent Therapy Evaluation: Progressing to PET/MR Imaging.

Camila Mosci1, Guido A Davidzon1, Andrew Quon1

  • 1Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H-0250, Stanford, CA 94305, USA.

PET Clinics
|May 10, 2016
PubMed
Summary

Positron emission tomography (PET) combined with computed tomography (CT) or magnetic resonance imaging (MRI) offers advanced diagnostic capabilities for head and neck cancer (HNC). These imaging techniques improve staging, restaging, and treatment monitoring for HNC patients.

More Related Videos

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

19.9K
MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

12.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

19.9K
MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

12.5K

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Diagnostic imaging is crucial for head and neck cancer (HNC) management, including staging, restaging, and treatment monitoring.
  • While MR imaging and CT are standard, they have limitations in assessing HNC.
  • Emerging PET-based imaging modalities are becoming integral to HNC patient care.

Purpose of the Study:

  • To outline the indications for using (18)F-2-fluoro-2-deoxy-D-glucose (FDG) PET/CT and PET/MR imaging in HNC.
  • To highlight the benefits of these advanced imaging techniques in managing HNC.
  • To provide a comprehensive overview of PET/CT and PET/MR in HNC treatment.

Main Methods:

  • Review of current literature on (18)F-FDG PET/CT and PET/MR imaging in HNC.
  • Discussion of established and evolving clinical applications.
  • Analysis of the role of PET imaging in different stages of HNC management.

Main Results:

  • (18)F-FDG PET/CT and PET/MR imaging demonstrate significant value in HNC staging and restaging.
  • These modalities offer improved accuracy over conventional CT and MR imaging in specific HNC scenarios.
  • PET imaging aids in treatment response assessment and detection of recurrence.

Conclusions:

  • (18)F-FDG PET/CT and PET/MR imaging are valuable tools for comprehensive HNC management.
  • Their use is indicated for improved diagnostic accuracy and treatment planning in HNC.
  • These advanced imaging techniques enhance patient outcomes through precise monitoring.